A comprehensive view of astrazeneca ab. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "CAS9 EFFECTOR PROTEINS WITH ENHANCED STABILITY"

INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR TREATING LUNG CANCER"

AstraZeneca expands Healthy Heart Africa program to 10 more countries in Africa starting in 2023; program intended to prevent, control hypertension, which accounted for 1 million deaths in Sub-Saharan Africa in 2019 according to World Heart Federation

AstraZeneca earns the Best Place to Work Certification across its operations in North Africa and Levant

AstraZeneca withdraws US COVID-19 vaccine application for Vaxzevria, shifts focus to antibody treatment Evusheld; Evusheld is approved in US to prevent COVID in immunocompromised people and in Europe as a preexposure prophylactic and as a treatment

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count